Notice2023-21439
National Cancer Institute; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 29, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 188 (Friday, September 29, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 188 (Friday, September 29, 2023)]
[Notices]
[Page 67321]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-21439]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the President's Cancer
Panel.
This will be a hybrid meeting held in-person and virtually and will
be open to the public, with in-person attendance limited to space
available. Individuals who plan to attend in-person or view the virtual
meeting and need special assistance or other reasonable accommodations,
should notify the Contact Person listed below in advance of the
meeting. The meeting can be accessed by clicking on the following link:
<a href="https://nci.rev.vbrick.com/#/webcasts/policyconsiderationsintersectiontechnpatientnav">https://nci.rev.vbrick.com/#/webcasts/policyconsiderationsintersectiontechnpatientnav</a>.
Name of Committee: President's Cancer Panel.
Date: December 7, 2023.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: Reducing Cancer Care Inequities: Policy Considerations
at the Intersection of Technology and Patient Navigation.
Place: Natcher Conference Center, NIH Building 45, Room E1/E2,
45 Center Drive, Bethesda, MD 20894 (Hybrid Meeting).
Contact Person: Maureen R. Johnson, Ph.D., Executive Secretary,
President's Cancer Panel, Special Assistant to the Director,
National Cancer Institute, NIH, 31 Center Drive, Room 11A48 MSC
2590, Bethesda, MD 20892, 240-781-3327, <a href="/cdn-cgi/l/email-protection#0f656067617c60617d4f626e66632161666721686079"><span class="__cf_email__" data-cfemail="ff959097918c90918dbf929e9693d1919697d1989089">[email protected]</span></a>.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: <a href="http://deainfo.nci.nih.gov/advisory/pcp/index.htm">http://deainfo.nci.nih.gov/advisory/pcp/index.htm</a>, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: September 26, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-21439 Filed 9-28-23; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 29, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.